Research graph
References from Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
10.1016/s1470-2045(22)00078-x · 2022 · External reference
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
10.1053/j.gastro.2021.06.008 · 2021 · External reference
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review
10.1001/jamaoncol.2020.3381 · 2021 · External reference
The human Musashi homolog 1 (MSI1) gene encoding the homologue of Musashi/Nrp-1, a neural RNA-binding protein putatively expressed in CNS stem cells and neural progenitor cells
10.1006/geno.1998.5456 · 1998 · External reference
Rna-binding protein Musashi2: developmentally regulated expression in neural precursor cells and subpopulations of neurons in mammalian CNS
10.1523/jneurosci.21-20-08091.2001 · 2001 · External reference
Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway
10.1038/labinvest.2016.71 · 2016 · External reference
Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation
10.1016/j.canlet.2016.10.007 · 2017 · External reference
Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT
10.2147/ott.s298438 · 2021 · External reference
Musashi-2 is a prognostic marker for the survival of patients with cervical cancer
2018 · External reference
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
10.21037/jtd-20-2787 · 2021 · External reference
Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer
2019 · External reference
Jolkinolide B: A comprehensive review of its physicochemical properties, analytical methods, synthesis and pharmacological activity
10.1016/j.phytochem.2022.113448 · 2022 · External reference
Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway
10.1016/j.jep.2021.114581 · 2022 · External reference
Jolkinolide B induces cell cycle arrest and apoptosis in MKN45 gastric cancer cells and inhibits xenograft tumor growth in vivo
10.1042/bsr20220341 · 2022 · External reference
Anti-metastatic effect of jolkinolide B and the mechanism of activity in breast cancer MDA-MB-231 cells
10.3892/ol.2015.3310 · 2015 · External reference
Regulatory networks defining EMT during cancer initiation and progression
10.1038/nrc3447 · 2013 · External reference
Epithelial-mesenchymal transitions in development and disease
10.1016/j.cell.2009.11.007 · 2009 · External reference
Molecular mechanisms of epithelial-mesenchymal transition
10.1038/nrm3758 · 2014 · External reference
Role of Cadherins in Cancer-A Review
10.3390/ijms21207624 · 2020 · External reference
Diagnostic accuracy of E-cadherin for malignanteffusions: a systematic review and meta-analysis
10.1136/postgradmedj-2019-137025 · 2020 · External reference
Signaling Pathways and Protein-Protein Interaction of Vimentin in Invasive and Migration Cells
10.1089/cell.2022.0025 · 2022 · External reference
Disordered clusters of Bak dimers rupture mitochondria during apoptosis
2017 · External reference
An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients
10.1177/2050640618774637 · 2018 · External reference
Predictive value of beta-catenin in bladder cancer: a systematic review and meta-analysis
2020 · External reference
Tumor microenvironment involvement in colorectal cancer progression via Wnt/beta-catenin pathway: Providing understanding of the complex mechanisms of chemoresistance
10.3748/wjg.v28.i26.3027 · 2022 · External reference
The relationship between beta-catenin and patient survival in colorectal cancer systematic review and meta-analysis
10.1016/j.critrevonc.2021.103337 · 2021 · External reference
Paeonol exerts antitumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/betacatenin signaling pathway
10.3892/ijmm.2020.4629 · 2020 · External reference
Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting beta-catenin signaling
2017 · External reference
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia
10.1038/nm.2187 · 2010 · External reference
Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program
10.1172/jci78440 · 2015 · External reference
Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation
10.1186/s13046-017-0617-y · 2017 · External reference
Musashi-2 promotes hepatitis Bvirus related hepatocellular carcinoma progression via the Wnt/beta-catenin pathway
2015 · External reference
